CoChat

Staphylococcus aureus Colonization of the Human Nose and Interaction with Other Microbiome Members

Laux, Claudia, Peschel, Andreas, Krismer, Bernhard · 2019 · Microbiology Spectrum
Cited by 136

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Staphylococcus aureus is usually regarded as a bacterial pathogen due to its ability to cause multiple types of invasive infections. Nevertheless, S. aureus colonizes about 30% of the human population asymptomatically in the nares, either transiently or persistently, and can therefore be regarded a human commensal as well, although carriage increases the risk of infection. Whereas many facets of the infection processes have been studied intensively, little is known about the commensal lifestyle of S. aureus . Recent studies highlight the major role of the composition of the highly variable nasal microbiota in promoting or inhibiting S. aureus colonization. Competition for limited nutrients, trace elements, and epithelial attachment sites, different susceptibilities to host defense molecules and the production of antimicrobial molecules by bacterial competitors may determine whether nasal bacteria outcompete each other. This chapter summarizes our knowledge about mechanisms that are used by S. aureus for efficient nasal colonization and strategies used by other nasal bacteria to interfere with its colonization. An improved understanding of naturally evolved mechanisms might enable us to develop new strategies for pathogen eradication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/microbiolspec.gpp3-0029-2018

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 71

  1. Krismer B Weidenmaier C Zipperer A Peschel A. 2017. The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat Rev Microbiol 15: 675–687 http://dx.doi.org/10.1038/nrmicro.2017.104. [PubMed][CrossRef] · DOI · Paper page
  2. Cole AM Tahk S Oren A Yoshioka D Kim YH Park A Ganz T. 2001. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 8: 1064–1069. [PubMed] · DOI · Paper page
  3. Zanger P Nurjadi D Gaile M Gabrysch S Kremsner PG. 2012. Hormonal contraceptive use and persistent Staphylococcus aureus nasal carriage. Clin Infect Dis 55: 1625–1632 http://dx.doi.org/10.1093/cid/cis778. [PubMed][CrossRef] · DOI
  4. Lipsky BA Pecoraro RE Chen MS Koepsell TD. 1987. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 10: 483–486 http://dx.doi.org/10.2337/diacare.10.4.483. [PubMed][CrossRef] · DOI · Paper page
  5. Armstrong-Esther CA Smith JE. 1976. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 3: 221–227 http://dx.doi.org/10.1080/03014467600001381. [PubMed][CrossRef] · DOI · Paper page
  6. Olsen K Falch BM Danielsen K Johannessen M Ericson Sollid JU Thune I Grimnes G Jorde R Simonsen GS Furberg AS. 2012. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels gender and smoking status. The Tromsø Staph and Skin Study. Eur J Clin Microbiol Infect Dis 31: 465–473 http://dx.doi.org/10.1007/s10096-011-1331-x. [PubMed][CrossRef] · DOI
  7. Camarinha-Silva A Jáuregui R Pieper DH Wos-Oxley ML. 2012. The temporal dynamics of bacterial communities across human anterior nares. Environ Microbiol Rep 4: 126–132 http://dx.doi.org/10.1111/j.1758-2229.2011.00313.x. [PubMed][CrossRef] · DOI · Paper page
  8. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339: 520–532 http://dx.doi.org/10.1056/NEJM199808203390806. [PubMed][CrossRef] · DOI · Paper page
  9. Bode LG Kluytmans JA Wertheim HF Bogaers D Vandenbroucke-Grauls CM Roosendaal R Troelstra A Box AT Voss A van der Tweel I van Belkum A Verbrugh HA Vos MC. 2010. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus . N Engl J Med 362: 9–17 http://dx.doi.org/10.1056/NEJMoa0808939. [PubMed][CrossRef] · DOI · Paper page
  10. Reagan DR Doebbeling BN Pfaller MA Sheetz CT Houston AK Hollis RJ Wenzel RP. 1991. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114: 101–106 http://dx.doi.org/10.7326/0003-4819-114-2-101. [PubMed][CrossRef] · DOI · Paper page
  11. Parras F Guerrero MC Bouza E Blázquez MJ Moreno S Menarguez MC Cercenado E. 1995. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 39: 175–179 http://dx.doi.org/10.1128/AAC.39.1.175. [PubMed][CrossRef] · DOI · Paper page
  12. Septimus EJ Schweizer ML. 2016. Decolonization in prevention of health care-associated infections. Clin Microbiol Rev 29: 201–222 http://dx.doi.org/10.1128/CMR.00049-15. [PubMed][CrossRef] · DOI · Paper page
  13. Antonov NK Garzon MC Morel KD Whittier S Planet PJ Lauren CT. 2015. High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population. Antimicrob Agents Chemother 59: 3350–3356 http://dx.doi.org/10.1128/AAC.00079-15. [PubMed][CrossRef] · DOI
  14. Kaspar U Kriegeskorte A Schubert T Peters G Rudack C Pieper DH Wos-Oxley M Becker K. 2016. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ Microbiol 18: 2130–2142 http://dx.doi.org/10.1111/1462-2920.12891. [PubMed][CrossRef] · DOI · Paper page
  15. Wertheim HFL Verveer J Boelens HAM van Belkum A Verbrugh HA Vos MC. 2005. Effect of mupirocin treatment on nasal pharyngeal and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob Agents Chemother 49: 1465–1467 http://dx.doi.org/10.1128/AAC.49.4.1465-1467.2005. [PubMed][CrossRef] · DOI
  16. Otto M. 2012. MRSA virulence and spread. Cell Microbiol 14: 1513–1521 http://dx.doi.org/10.1111/j.1462-5822.2012.01832.x. [PubMed][CrossRef] · DOI · Paper page
  17. DeLeo FR Otto M Kreiswirth BN Chambers HF. 2010. Community-associated meticillin-resistant Staphylococcus aureus . Lancet 375: 1557–1568 http://dx.doi.org/10.1016/S0140-6736(09)61999-1. [CrossRef] · DOI · Paper page
  18. Human Microbiome Project Consortium. 2012. Structure function and diversity of the healthy human microbiome. Nature 486: 207–214 http://dx.doi.org/10.1038/nature11234. [PubMed][CrossRef] · DOI · Paper page
  19. Casewell MW Hill RL. 1986. The carrier state: methicillin-resistant Staphylococcus aureus . J Antimicrob Chemother 18 (Suppl A) : 1–12. [PubMed][CrossRef] · DOI · Paper page
  20. Peacock SJ de Silva I Lowy FD. 2001. What determines nasal carriage of Staphylococcus aureus ? Trends Microbiol 9: 605–610 http://dx.doi.org/10.1016/S0966-842X(01)02254-5. [CrossRef] · DOI · Paper page
  21. Geoghegan JA Irvine AD Foster TJ. 2017. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol 26: 484–497. [PubMed][CrossRef] · DOI · Paper page
  22. Becker K Heilmann C Peters G. 2014. Coagulase-negative staphylococci. Clin Microbiol Rev 27: 870–926 http://dx.doi.org/10.1128/CMR.00109-13. [PubMed][CrossRef] · DOI · Paper page
  23. Krismer B Liebeke M Janek D Nega M Rautenberg M Hornig G Unger C Weidenmaier C Lalk M Peschel A. 2014. Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation inthe human nose. PLoS Pathog 10: e1003862 http://dx.doi.org/10.1371/journal.ppat.1003862. [PubMed][CrossRef] · DOI · Paper page
  24. Wos-Oxley ML Plumeier I von Eiff C Taudien S Platzer M Vilchez-Vargas R Becker K Pieper DH. 2010. A poke into the diversity and associations within human anterior nare microbial communities. ISME J 4: 839–851 http://dx.doi.org/10.1038/ismej.2010.15. [PubMed][CrossRef] · DOI · Paper page
  25. Quercia S Candela M Giuliani C Turroni S Luiselli D Rampelli S Brigidi P Franceschi C Bacalini MG Garagnani P Pirazzini C. 2014. From lifetime to evolution: timescales of human gut microbiota adaptation. Front Microbiol 5: 587 http://dx.doi.org/10.3389/fmicb.2014.00587. [PubMed][CrossRef] · DOI · Paper page
  26. Kloos WE Schleifer KH. 1975. Isolation and characterization of staphylococci from human skin. II. Descriptions of four new species: Staphylococcus warneri Staphylococcus capitis Staphylococcus hominis and Staphylococcus simulans . Int J Syst Bacteriol 25: 62–79 http://dx.doi.org/10.1099/00207713-25-1-62. [CrossRef] · DOI · Paper page
  27. Bieber L Kahlmeter G. 2010. Staphylococcus lugdunensis in several niches of the normal skin flora. Clin Microbiol Infect 16: 385–388 http://dx.doi.org/10.1111/j.1469-0691.2009.02813.x. [PubMed][CrossRef] · DOI
  28. Hu L Umeda A Kondo S Amako K. 1995. Typing of Staphylococcus aureus colonising human nasal carriers by pulsed-field gel electrophoresis. J Med Microbiol 42: 127–132 http://dx.doi.org/10.1099/00222615-42-2-127. [PubMed][CrossRef] · DOI · Paper page
  29. Hu L Umeda A Amako K. 1995. Typing of Staphylococcus epidermidis colonizing in human nares by pulsed-field gel electrophoresis. Microbiol Immunol 39: 315–319 http://dx.doi.org/10.1111/j.1348-0421.1995.tb02207.x. [PubMed][CrossRef] · DOI
  30. Warnke P Devide A Weise M Frickmann H Schwarz NG Schäffler H Ottl P Podbielski A. 2016. Utilizing moist or dry swabs for the sampling of nasal MRSA carriers? An in vivo and in vitro study. PLoS One 11: e0163073 http://dx.doi.org/10.1371/journal.pone.0163073. [PubMed][CrossRef] · DOI
  31. Verhoeven PO Grattard F Carricajo A Lucht F Cazorla C Garraud O Pozzetto B Berthelot P. 2012. An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus . Clin Microbiol Infect 18: 551–557 http://dx.doi.org/10.1111/j.1469-0691.2011.03611.x. [PubMed][CrossRef] · DOI
  32. Hanssen AM Kindlund B Stenklev NC Furberg AS Fismen S Olsen RS Johannessen M Sollid JUE. 2017. Localization of Staphylococcus aureus in tissue from the nasal vestibule in healthy carriers. BMC Microbiol 17: 89 http://dx.doi.org/10.1186/s12866-017-0997-3. [PubMed][CrossRef] · DOI
  33. Weidenmaier C Goerke C Wolz C. 2012. Staphylococcus aureus determinants for nasal colonization. Trends Microbiol 20: 243–250 http://dx.doi.org/10.1016/j.tim.2012.03.004. [PubMed][CrossRef] · DOI
  34. Casado B Pannell LK Iadarola P Baraniuk JN. 2005. Identification of human nasal mucous proteins using proteomics. Proteomics 5: 2949–2959 http://dx.doi.org/10.1002/pmic.200401172. [PubMed][CrossRef] · DOI · Paper page
  35. Tomazic PV Birner-Gruenberger R Leitner A Obrist B Spoerk S Lang-Loidolt D. 2014. Nasal mucus proteomic changes reflect altered immune responses and epithelial permeability in patients with allergic rhinitis. J Allergy Clin Immunol 133: 741–750 http://dx.doi.org/10.1016/j.jaci.2013.09.040. [PubMed][CrossRef] · DOI
  36. Koziel J Potempa J. 2013. Protease-armed bacteria in the skin. Cell Tissue Res 351: 325–337 http://dx.doi.org/10.1007/s00441-012-1355-2. [PubMed][CrossRef] · DOI
  37. Baur S Rautenberg M Faulstich M Grau T Severin Y Unger C Hoffmann WH Rudel T Autenrieth IB Weidenmaier C. 2014. A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonization. PLoS Pathog 10: e1004089 http://dx.doi.org/10.1371/journal.ppat.1004089. [PubMed][CrossRef] · DOI · Paper page
  38. Weidenmaier C Kokai-Kun JF Kristian SA Chanturiya T Kalbacher H Gross M Nicholson G Neumeister B Mond JJ Peschel A. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization a major risk factor in nosocomial infections. Nat Med 10: 243–245 http://dx.doi.org/10.1038/nm991. [PubMed][CrossRef] · DOI · Paper page
  39. Mulcahy ME Geoghegan JA Monk IR O’Keeffe KM Walsh EJ Foster TJ McLoughlin RM. 2012. Nasal colonisation by Staphylococcus aureus depends upon clumping factor B binding to the squamous epithelial cell envelope protein loricrin. PLoS Pathog 8: e1003092 http://dx.doi.org/10.1371/journal.ppat.1003092. [PubMed][CrossRef] · DOI · Paper page
  40. Weidenmaier C Peschel A. 2008. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 6: 276–287 http://dx.doi.org/10.1038/nrmicro1861. [PubMed][CrossRef] · DOI · Paper page
  41. Winstel V Kühner P Salomon F Larsen J Skov R Hoffmann W Peschel A Weidenmaier C. 2015. Wall teichoic acid glycosylation governs Staphylococcus aureus nasal colonization. MBio 6: e00632-15 http://dx.doi.org/10.1128/mBio.00632-15. [PubMed][CrossRef] · DOI
  42. Schade J Weidenmaier C. 2016. Cell wall glycopolymers of Firmicutes and their role as nonprotein adhesins. FEBS Lett 590: 3758–3771 http://dx.doi.org/10.1002/1873-3468.12288. [PubMed][CrossRef] · DOI
  43. O’Brien LM Walsh EJ Massey RC Peacock SJ Foster TJ. 2002. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol 4: 759–770 http://dx.doi.org/10.1046/j.1462-5822.2002.00231.x. [PubMed][CrossRef] · DOI · Paper page
  44. Wertheim HF Walsh E Choudhurry R Melles DC Boelens HA Miajlovic H Verbrugh HA Foster T van Belkum A. 2008. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med 5: e17 http://dx.doi.org/10.1371/journal.pmed.0050017. [PubMed][CrossRef] · DOI · Paper page
  45. Foster TJ Geoghegan JA Ganesh VK Höök M. 2014. Adhesion invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus . Nat Rev Microbiol 12: 49–62 http://dx.doi.org/10.1038/nrmicro3161. [PubMed][CrossRef] · DOI · Paper page
  46. Askarian F Ajayi C Hanssen AM van Sorge NM Pettersen I Diep DB Sollid JU Johannessen M. 2016. The interaction between Staphylococcus aureus SdrD and desmoglein 1 is important for adhesion to host cells. Sci Rep 6: 22134 http://dx.doi.org/10.1038/srep22134. [PubMed][CrossRef] · DOI · Paper page
  47. Hammers CM Stanley JR. 2013. Desmoglein-1 differentiation and disease. J Clin Invest 123: 1419–1422 http://dx.doi.org/10.1172/JCI69071. [PubMed][CrossRef] · DOI · Paper page
  48. Roche FM Meehan M Foster TJ. 2003. The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 149: 2759–2767 http://dx.doi.org/10.1099/mic.0.26412-0. [PubMed][CrossRef] · DOI · Paper page
  49. Schaffer AC Solinga RM Cocchiaro J Portoles M Kiser KB Risley A Randall SM Valtulina V Speziale P Walsh E Foster T Lee JC. 2006. Immunization with Staphylococcus aureus clumping factor B a major determinant in nasal carriage reduces nasal colonization in a murine model. Infect Immun 74: 2145–2153 http://dx.doi.org/10.1128/IAI.74.4.2145-2153.2006. [PubMed][CrossRef] · DOI · Paper page
  50. Brugger SD Bomar L Lemon KP. 2016. Commensal-pathogen interactions along the human nasal passages. PLoS Pathog 12: e1005633 http://dx.doi.org/10.1371/journal.ppat.1005633. [PubMed][CrossRef] · DOI
  51. Janek D Zipperer A Kulik A Krismer B Peschel A. 2016. High frequency and diversity of antimicrobial activities produced by nasal Staphylococcus strains against bacterial competitors. PLoS Pathog 12: e1005812 http://dx.doi.org/10.1371/journal.ppat.1005812. [PubMed][CrossRef] · DOI · Paper page
  52. Lee H Kim HY. 2011. Lantibiotics class I bacteriocins from the genus Bacillus . J Microbiol Biotechnol 21: 229–235. [PubMed] · DOI
  53. Bierbaum G Sahl HG. 2009. Lantibiotics: mode of action biosynthesis and bioengineering. Curr Pharm Biotechnol 10: 2–18 http://dx.doi.org/10.2174/138920109787048616. [PubMed][CrossRef] · DOI · Paper page
  54. Allgaier H Jung G Werner RG Schneider U Zähner H. 1986. Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur J Biochem 160: 9–22 http://dx.doi.org/10.1111/j.1432-1033.1986.tb09933.x. [PubMed][CrossRef] · DOI · Paper page
  55. Kaletta C Entian KD Kellner R Jung G Reis M Sahl HG. 1989. Pep5 a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol 152: 16–19 http://dx.doi.org/10.1007/BF00447005. [PubMed][CrossRef] · DOI
  56. van de Kamp M van den Hooven HW Konings RN Bierbaum G Sahl HG Kuipers OP Siezen RJ de Vos WM Hilbers CW van de Ven FJ. 1995. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur J Biochem 230: 587–600 http://dx.doi.org/10.1111/j.1432-1033.1995.tb20600.x. [PubMed][CrossRef] · DOI
  57. Ekkelenkamp MB Hanssen M Danny Hsu ST de Jong A Milatovic D Verhoef J van Nuland NA. 2005. Isolation and structural characterization of epilancin 15X a novel lantibiotic from a clinical strain of Staphylococcus epidermidis . FEBS Lett 579: 1917–1922 http://dx.doi.org/10.1016/j.febslet.2005.01.083. [PubMed][CrossRef] · DOI · Paper page
  58. Heidrich C Pag U Josten M Metzger J Jack RW Bierbaum G Jung G Sahl HG. 1998. Isolation characterization and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol 64: 3140–3146. [PubMed] · DOI · Paper page
  59. Navaratna MA Sahl HG Tagg JR. 1998. Two-component anti- Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol 64: 4803–4808. [PubMed] · DOI · Paper page
  60. Sashihara T Kimura H Higuchi T Adachi A Matsusaki H Sonomoto K Ishizaki A. 2000. A novel lantibiotic nukacin ISK-1 of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci Biotechnol Biochem 64: 2420–2428 http://dx.doi.org/10.1271/bbb.64.2420. [PubMed][CrossRef] · DOI
  61. Wilaipun P Zendo T Okuda K Nakayama J Sonomoto K. 2008. Identification of the nukacin KQU-131 a new type-A(II) lantibiotic produced by Staphylococcus hominis KQU-131 isolated from Thai fermented fish product (Pla-ra). Biosci Biotechnol Biochem 72: 2232–2235 http://dx.doi.org/10.1271/bbb.80239. [PubMed][CrossRef] · DOI
  62. Kumar R Jangir PK Das J Taneja B Sharma R. 2017. Genome analysis of Staphylococcus capitis TE8 reveals repertoire of antimicrobial peptides and adaptation strategies for growth on human skin. Sci Rep 7: 10447 http://dx.doi.org/10.1038/s41598-017-11020-7. [PubMed][CrossRef] · DOI
  63. Christensen GJM Scholz CFP Enghild J Rohde H Kilian M Thürmer A Brzuszkiewicz E Lomholt HB Brüggemann H. 2016. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genomics 17: 152 http://dx.doi.org/10.1186/s12864-016-2489-5. [PubMed][CrossRef] · DOI · Paper page
  64. Brzuszkiewicz E Weiner J Wollherr A Thürmer A Hüpeden J Lomholt HB Kilian M Gottschalk G Daniel R Mollenkopf HJ Meyer TF Brüggemann H. 2011. Comparative genomics and transcriptomics of Propionibacterium acnes . PLoS One 6: e21581 http://dx.doi.org/10.1371/journal.pone.0021581. [PubMed][CrossRef] · DOI · Paper page
  65. Sugimoto S Iwamoto T Takada K Okuda K Tajima A Iwase T Mizunoe Y. 2013. Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J Bacteriol 195: 1645–1655 http://dx.doi.org/10.1128/JB.01672-12. [PubMed][CrossRef] · DOI · Paper page
  66. Lemon KP Klepac-Ceraj V Schiffer HK Brodie EL Lynch SV Kolter R. 2010. Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio 1: e00129-10. [PubMed][CrossRef] · DOI · Paper page
  67. Uehara Y Kikuchi K Nakamura T Nakama H Agematsu K Kawakami Y Maruchi N Totsuka K. 2001. H(2)O(2) produced by viridans group streptococci may contribute to inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns. Clin Infect Dis 32: 1408–1413 http://dx.doi.org/10.1086/320179. [PubMed][CrossRef] · DOI · Paper page
  68. Regev-Yochay G Dagan R Raz M Carmeli Y Shainberg B Derazne E Rahav G Rubinstein E. 2004. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 292: 716–720 http://dx.doi.org/10.1001/jama.292.6.716. [PubMed][CrossRef] · DOI · Paper page
  69. Wollenberg MS Claesen J Escapa IF Aldridge KL Fischbach MA Lemon KP. 2014. Propionibacterium-produced coproporphyrin III induces Staphylococcus aureus aggregation and biofilm formation. MBio 5: e01286-14 http://dx.doi.org/10.1128/mBio.01286-14. [PubMed][CrossRef] · DOI · Paper page
  70. Hanzelmann D Joo HS Franz-Wachtel M Hertlein T Stevanovic S Macek B Wolz C Götz F Otto M Kretschmer D Peschel A. 2016. Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants. Nat Commun 7: 12304 http://dx.doi.org/10.1038/ncomms12304. [PubMed][CrossRef] · DOI · Paper page
  71. Riechelmann H Essig A Deutschle T Rau A Rothermel B Weschta M. 2005. Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls. Allergy 60: 1418–1423 http://dx.doi.org/10.1111/j.1398-9995.2005.00902.x. [PubMed][CrossRef] · DOI · Paper page

Cited by

Metadata

Authors
Laux, C., Peschel, A., & Krismer, B.
Venue
Microbiology Spectrum
Published
2019-04-12
Volume
7
Issue
2
ISSN
2165-0497
Cited by
136
References
17
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.